Cellmat Therapeutics, Foreign Investors Net Sell 3,976 Shares... Stock Price Down 3.5%
Sselma Therapeutics has newly appeared among the top searched stocks.
As of 1:31 PM on the 29th, Sselma Therapeutics is trading at 6,890 KRW, down 3.5% from the previous day. This represents a 28.54% increase compared to June 1. Sselma Therapeutics is known as a distributor of gift certificate discounts and dental materials.
Today, foreigners are tentatively recorded as net sellers of 3,976 shares. Over the past five days, individual investors have been net buyers of 95,411 shares, while foreigners and institutions have been net sellers of 52,174 shares and 8,962 shares, respectively.
[Table] Net Trading Volume of Foreigners and Institutions (Unit: shares)
※ This article was generated in real-time by an article automation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
Hot Picks Today
!["Not Everyone Can Afford This: Inside the World of the True Top 0.1% [Luxury World]"](https://cwcontent.asiae.co.kr/asiaresize/93/2026051507261063923_1778797570.png)
"Not Everyone Can Afford This: Inside the World of the True Top 0.1% [Luxury World]"
- While Everyone Focused on Samsung and Nix, This Company Soared 50%... Hit Record Highs for 4 Days [Weekend Money]
- "Plunged During the War, Now Surging Again"... The Real Reason Behind the 6% One-Day Silver Market Rally [Weekend Money]
- Incoming Fed Chairman Kevin Walsh to Sell $2.52 Million Worth of Coupang Shares
- "Target Price Set at 970,000 Won"... Top Investors Already Watching, Only an 'Uptrend' Remains [Weekend Money]
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
